This post was originally published on this site
Bristol-Myers Squibb announced earnings per share of $1.83 on revenue of $11.99B. Analysts polled by Investing.com anticipated EPS of $1.8 on revenue of $12.09B.
Bristol-Myers Squibb shares are up 2% from the beginning of the year, still down 8.14% from its 52 week high of $69.75 set on August 23, 2021. They are outperforming the S&P Global 100 which is down 2.77% from the start of the year.
Bristol-Myers Squibb’s report follows an earnings beat by UnitedHealth on January 19, who reported EPS of $4.48 on revenue of $73.74B, compared to forecasts EPS of $4.3 on revenue of $72.98B.
J&J had beat expectations on January 25 with fourth quarter EPS of $2.13 on revenue of $24.8B, compared to forecast for EPS of $2.12 on revenue of $25.28B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
